908 DEVICES INC (MASS)

US65443P1021 - Common Stock

1.98  -0.03 (-1.49%)

Premarket: 2.36 +0.38 (+19.19%)

Fundamental Rating

3

Taking everything into account, MASS scores 3 out of 10 in our fundamental rating. MASS was compared to 126 industry peers in the Electronic Equipment, Instruments & Components industry. MASS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, MASS is valued expensive at the moment.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

MASS had negative earnings in the past year.
In the past year MASS has reported a negative cash flow from operations.
In the past 5 years MASS always reported negative net income.
In the past 5 years MASS reported 4 times negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -33.76%, MASS is not doing good in the industry: 79.34% of the companies in the same industry are doing better.
MASS's Return On Equity of -45.93% is on the low side compared to the rest of the industry. MASS is outperformed by 78.51% of its industry peers.
Industry RankSector Rank
ROA -33.76%
ROE -45.93%
ROIC N/A
ROA(3y)-13.42%
ROA(5y)-16.65%
ROE(3y)-16.64%
ROE(5y)-46.41%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MASS's Gross Margin of 50.81% is amongst the best of the industry. MASS outperforms 86.78% of its industry peers.
MASS's Gross Margin has declined in the last couple of years.
MASS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.15%
GM growth 5Y-2.15%

More info and screens

6

2. Health

2.1 Basic Checks

MASS does not have a ROIC to compare to the WACC, probably because it is not profitable.
MASS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MASS has more shares outstanding
MASS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MASS has an Altman-Z score of -0.67. This is a bad value and indicates that MASS is not financially healthy and even has some risk of bankruptcy.
MASS has a worse Altman-Z score (-0.67) than 80.99% of its industry peers.
MASS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.67
ROIC/WACCN/A
WACC10.05%

2.3 Liquidity

A Current Ratio of 4.24 indicates that MASS has no problem at all paying its short term obligations.
MASS has a Current ratio of 4.24. This is in the better half of the industry: MASS outperforms 72.73% of its industry peers.
MASS has a Quick Ratio of 3.54. This indicates that MASS is financially healthy and has no problem in meeting its short term obligations.
MASS has a Quick ratio of 3.54. This is in the better half of the industry: MASS outperforms 79.34% of its industry peers.
Industry RankSector Rank
Current Ratio 4.24
Quick Ratio 3.54

More info and screens

4

3. Growth

3.1 Past

MASS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.40%, which is quite impressive.
Looking at the last year, MASS shows a quite strong growth in Revenue. The Revenue has grown by 16.08% in the last year.
The Revenue has been growing by 17.90% on average over the past years. This is quite good.
EPS 1Y (TTM)31.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
Revenue 1Y (TTM)16.08%
Revenue growth 3Y23.16%
Revenue growth 5Y17.9%
Sales Q2Q%17.32%

3.2 Future

MASS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.69% yearly.
Based on estimates for the next years, MASS will show a quite strong growth in Revenue. The Revenue will grow by 19.31% on average per year.
EPS Next Y-70.3%
EPS Next 2Y-7.17%
EPS Next 3Y-1.69%
EPS Next 5YN/A
Revenue Next Year13.48%
Revenue Next 2Y14.78%
Revenue Next 3Y19.31%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MASS. In the last year negative earnings were reported.
Also next year MASS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.17%
EPS Next 3Y-1.69%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MASS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

908 DEVICES INC

NASDAQ:MASS (1/14/2025, 8:00:01 PM)

Premarket: 2.36 +0.38 (+19.19%)

1.98

-0.03 (-1.49%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners73.09%
Inst Owner Change0%
Ins Owners7.63%
Ins Owner Change1.23%
Market Cap68.94M
Analysts85.45
Price Target5.78 (191.92%)
Short Float %5.16%
Short Ratio4.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)61.44%
Min EPS beat(2)9.01%
Max EPS beat(2)113.88%
EPS beat(4)4
Avg EPS beat(4)37.03%
Min EPS beat(4)9.01%
Max EPS beat(4)113.88%
EPS beat(8)6
Avg EPS beat(8)20.83%
EPS beat(12)10
Avg EPS beat(12)18.51%
EPS beat(16)11
Avg EPS beat(16)-40.5%
Revenue beat(2)1
Avg Revenue beat(2)-4.25%
Min Revenue beat(2)-10.3%
Max Revenue beat(2)1.8%
Revenue beat(4)2
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-10.3%
Max Revenue beat(4)5.41%
Revenue beat(8)5
Avg Revenue beat(8)2.76%
Revenue beat(12)8
Avg Revenue beat(12)2.58%
Revenue beat(16)12
Avg Revenue beat(16)5.11%
PT rev (1m)0%
PT rev (3m)-62.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-72.03%
EPS NY rev (1m)0%
EPS NY rev (3m)-55.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-25.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.25
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 0.93
EV/EBITDA N/A
EPS(TTM)-0.83
EYN/A
EPS(NY)-1.3
Fwd EYN/A
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)-0.86
OCFYN/A
SpS1.58
BVpS3.76
TBVpS2.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.76%
ROE -45.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.81%
FCFM N/A
ROA(3y)-13.42%
ROA(5y)-16.65%
ROE(3y)-16.64%
ROE(5y)-46.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.15%
GM growth 5Y-2.15%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.47%
Cap/Sales 1.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.24
Quick Ratio 3.54
Altman-Z -0.67
F-Score5
WACC10.05%
ROIC/WACCN/A
Cap/Depr(3y)97.56%
Cap/Depr(5y)67.44%
Cap/Sales(3y)3.4%
Cap/Sales(5y)2.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
EPS Next Y-70.3%
EPS Next 2Y-7.17%
EPS Next 3Y-1.69%
EPS Next 5YN/A
Revenue 1Y (TTM)16.08%
Revenue growth 3Y23.16%
Revenue growth 5Y17.9%
Sales Q2Q%17.32%
Revenue Next Year13.48%
Revenue Next 2Y14.78%
Revenue Next 3Y19.31%
Revenue Next 5YN/A
EBIT growth 1Y17.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.82%
EBIT Next 3Y10.95%
EBIT Next 5YN/A
FCF growth 1Y-15.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.59%
OCF growth 3YN/A
OCF growth 5YN/A